Table 1. Associations between patient characteristics and ORAOV1 gene amplification (n = 94).
Patients characteristics | ORAOV1 | P-values | |
---|---|---|---|
Amp (−) | Amp (+) | ||
Number | 45 | 49 | |
Age (years) | |||
<70 | 33 | 34 | 0.82 |
>70 | 12 | 15 | |
Sex | |||
Male | 39 | 43 | 1.00 |
Female | 6 | 6 | |
Location | |||
Ut or Mt | 20 | 35 | 0.012* |
Lt or Ae | 25 | 14 | |
Tumor differentiation | |||
Well or moderate | 41 | 36 | 0.033* |
Poor | 4 | 13 | |
pStage | |||
IIIA | 17 | 26 | 0.15 |
IIIB or IIIC | 28 | 23 | |
Lymphatic invasion | |||
0 | 9 | 8 | 0.79 |
1 or 2 | 36 | 41 | |
Vascular invasion | |||
0 | 33 | 38 | 0.81 |
1 | 12 | 11 | |
Residual cancer | |||
0 | 7 | 5 | 0.54 |
1 or 2 | 38 | 44 |
Abbreviations: Amp, amplification; Ut, upper thoracic esophagus; Mt, middle thoracic esophagus; Lt, lower thoracic esophagus; Ae, abdominal esophagus.